Marta Dzhus

Prof. Marta Dzhus

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in Disaster Medicine and Public Health Preparedness
Verified
Journal Article
Open access
PDF file
MDMarta Dzhus
Marta Dzhus
IGIryna Golovach
Iryna Golovach
Authors explore the influence of Russian aggression on Ukrainian health care and humanitarian crises. On February 24, 2022, Ukraine faced an unprovoked brutal Russian invasion resulting in multiple negative consequences. During the 3 mo of full-scale war, Russians damaged more than 600 hospitals and killed at least 12 medics. Access to health care is severely impacted due to security concerns, restricted mobility, broken supply chains, and mass population displacement. Health care continues to come under attack (including attacks against health facilities, transport, personnel, patients, supplies, and warehouses), with a total of 295 attacks on health care, resulting in 59 injuries and 76 deaths, reported between February 24 and June 15. Ministry of Health reported that 1658 medical workers had been forced to change their residence and became employed in other regions of the country. Russian aggression negatively influenced not only the medical system and economics, but it led to a humanitarian crisis in the whole of Ukraine.

27 July 2023 in Sustainability
Verified
Journal Article
Open access
PDF file
Krzysztof GoniewiczKrzysztof Goniewicz
Krzysztof Goniewicz
FBFrederick Burkle
Frederick Burkle
MDMarta Dzhus
Marta Dzhus
Amir Khorram-ManeshAmir Khorram-Manesh
Amir Khorram-Manesh
The protracted war in Ukraine, sparked in 2014 and persistently escalating, has significantly impacted the country’s healthcare system. It has amplified existing challenges, such as shortages of medical supplies and personnel, outdated infrastructure, and restricted access to healthcare services. Destruction of medical facilities, non-adherence to prevention and treatment standards, lack of medical personnel and supplies, and logistical disruptions are hampering the provision of timely healthcare to the Ukrainian population. This study employed a rapid review methodology to synthesize available research concerning the healthcare crisis in Ukraine, with an explicit focus on the war’s sustained impact on the healthcare system. Through this review, a series of critical challenges facing Ukraine’s healthcare system were identified. These included the shortage of medical supplies and personnel, insufficient infrastructure, and funding deficits. Additionally, the review brought to light various interventions and strategies aimed at counteracting these challenges. These comprised international aid and support, initiatives enhancing the resilience of the Ukrainian health system, and others. Given the ongoing war, this review highlighted the pressing need for continuous support and investment in the Ukrainian healthcare system. This commitment is essential to guarantee access to quality healthcare for the Ukrainian population during the war and in its aftermath. The findings presented here can serve as a guide for policymakers and healthcare professionals working not only in Ukraine but also in other regions impacted by war. These insights can inform the development and implementation of effective strategies and interventions tailored to such challenging contexts.

22 June 2015 in Experimental Oncology
Verified
Journal Article
Closed access
BBB T Bilynsky
B T Bilynsky
MDMarta Dzhus
Marta Dzhus
RLR I Litvinyak
R I Litvinyak
Symptomatology of oncological diseases consists not only of local symptoms caused by the primary malignancy or its metastases, but also by general systemic signs that are not directly connected with the tumor. These symptoms are mostly associated with autoimmunity or endocrine influences. In many cases, the source of paraneoplastic syndromes (PNS) is unknown. Nearly 15% of oncological patients demonstrate these syndromes but it is diagnosed much more rarely. The survey of the numerous PNS is offered. The significance of the PNS differs for oncologists and other physicians who encounter it in their practice. The reason of those differences, as well as the connection between PNS and cancer toxicity is discussed. The experience of antitoxic therapy (hemosorption, lymphosorption, enterosorption) used in our clinic in the previous years is overviewed.

30 June 2020 in Annals of Geriatric Medicine and Research
Verified
Journal Article
Open access
PDF file
MDMarta Dzhus
Marta Dzhus
MDMaria Dzhus
Maria Dzhus
MMMarta Masnyi
Marta Masnyi
MKMyroslava Kulyk
Myroslava Kulyk
HMHalyna Mostbauer
Halyna Mostbauer
CBCharlotte Beaudart
Charlotte Beaudart
The SarQoL, a quality-of-life questionnaire specific to sarcopenia, was developed in 2015 and has since been translated into a number of other languages. The main reason to introduce this new Ukrainian version of the questionnaire was to measure sarcopenic individuals’ perceptions regarding their positions in life in the context of their culture and value systems. The questionnaire was translated using a forward-backward approach with a pre-test. A total of 49 participants were recruited for the validation study. Sarcopenia was diagnosed according to the Ishii test. The validation analyses included discriminative power, internal consistency, floor and ceiling effects, construct validity, and test-retest reliability. We compared the SarQoL questionnaire to the Short-Form 36 and the EuroQoL-5 Dimensions. A total of 28 participants out of 49 were categorized as probably sarcopenic. They had a significantly lower quality of life (overall score 58.43±17.13 vs. 69.89±13.31; p=0.014). The internal consistency was excellent (α=0.898), with none of the domains showing a disproportionate influence on the homogeneity of the questionnaire. Convergent construct validity was also confirmed. The results indicated a near-perfect degree of test-retest reliability. The first Ukrainian version of the questionnaire is equivalent to the available original English version.

1 January 2023 in Rheumatology
Verified
Journal Article
Open access
MDMarta Dzhus
Marta Dzhus
HMHalyna Mostbauer
Halyna Mostbauer
Introduction: Takayasu arteritis (TAK) is a granulomatous inflammation of vessels of large diameter, mainly affecting the aorta and its proximal branches, which is more common in young women. The incidence of coronary artery disease in TAK is unknown and not sufficiently studied.Material and Methods: A literature review was performed for the period 2003 to 2023 using a search of the PubMed and Scopus scientific databases. We used the following key words to search the academic journal data-bases: “Takayasu arteritis”, “coronary angiography”, “myocardial revascularization”, “coronary artery disease”, “angina pectoris”, and “myocardial infarction”.Results: The analysis of studies showed that coronary artery lesions (CAL) in TAK are not uncommon, being identified particularly in children and young individuals. Pathology of the coronary arteries increases the morbidity and mortality of TAK patients. In TAK, the ostia and proximal segments of the coronary arteries are more frequently affected, presenting as stenosis or occlusion with the development of stable coronary artery disease, unstable coronary artery disease, acute myocardial infarction, and sudden death. The diagnosis of TAK and coronary artery pathology is often complicated due to non-specific manifestations and frequently the absence of symptoms. The treatment of patients with TAK with CAL is challenging and requires both pharmacological therapy and interventional or surgical methods of myocardial revascularization.Conclusions: Takayasu arteritis is a more prevalent cause of CAL development, especially in young patients, than previously believed, and cardiovascular death due to CAL is not rare. Early diagnosis of TAK with CAL, particularly occlusion or hemodynamically significant stenosis, and the prompt initiation of appropriate treatment prevent dangerous complications, reduce mortality, and improve prognosis.

4 June 2022 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
MDMarta Dzhus
Marta Dzhus
TKTetiana A. Karasevska
Tetiana A. Karasevska
VTVira M. Tsaralunga
Vira M. Tsaralunga
AYAlla V. Yurchenko
Alla V. Yurchenko
OIOlexiy I. Ivashkivsky
Olexiy I. Ivashkivsky